These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35418601)

  • 1. Brain integrity is altered by hepatic APOE ε4 in humanized-liver mice.
    Giannisis A; Patra K; Edlund AK; Nieto LA; Benedicto-Gras J; Moussaud S; de la Rosa A; Twohig D; Bengtsson T; Fu Y; Bu G; Bial G; Foquet L; Hammarstedt C; Strom S; Kannisto K; Raber J; Ellis E; Nielsen HM
    Mol Psychiatry; 2022 Aug; 27(8):3533-3543. PubMed ID: 35418601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer's disease and mild cognitive impairment.
    Giannisis A; Al-Grety A; Carlsson H; Howell JC; Hu WT; Kultima K; Nielsen HM
    Alzheimers Res Ther; 2023 Jul; 15(1):119. PubMed ID: 37400888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
    Chen Q; Wang T; Kang D; Chen L
    Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.
    Riddell DR; Zhou H; Atchison K; Warwick HK; Atkinson PJ; Jefferson J; Xu L; Aschmies S; Kirksey Y; Hu Y; Wagner E; Parratt A; Xu J; Li Z; Zaleska MM; Jacobsen JS; Pangalos MN; Reinhart PH
    J Neurosci; 2008 Nov; 28(45):11445-53. PubMed ID: 18987181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE ε4 allele elevates the expressions of inflammatory factors and promotes Alzheimer's disease progression: A comparative study based on Han and She populations in the Wenzhou area.
    Fan YY; Cai QL; Gao ZY; Lin X; Huang Q; Tang W; Liu JH
    Brain Res Bull; 2017 Jun; 132():39-43. PubMed ID: 28461186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease.
    Panitch R; Hu J; Xia W; Bennett DA; Stein TD; Farrer LA; Jun GR
    Alzheimers Res Ther; 2022 Feb; 14(1):30. PubMed ID: 35139885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo.
    Dieckmann M; Beil FT; Mueller B; Bartelt A; Marshall RP; Koehne T; Amling M; Ruether W; Cooper JA; Humphries SE; Herz J; Niemeier A
    J Bone Miner Res; 2013 Feb; 28(2):236-45. PubMed ID: 22991192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
    Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
    Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
    Lozupone M; Imbimbo BP; Balducci C; Lo Vecchio F; Bisceglia P; Latino RR; Leone M; Dibello V; Solfrizzi V; Greco A; Daniele A; Watling M; Seripa D; Panza F
    Alzheimers Dement; 2023 Jan; 19(1):353-368. PubMed ID: 35900209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Effect of Societal Factors on APOE-ε2 and ε4 Carriers' Brain Health: A Systematic Review.
    Aravena JM; Lee J; Schwartz AE; Nyhan K; Wang SY; Levy BR
    J Gerontol A Biol Sci Med Sci; 2024 Feb; 79(2):. PubMed ID: 37792627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
    Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
    J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer's Disease.
    Zverova M; Kitzlerova E; Fisar Z; Jirak R; Hroudova J; Benakova H; Lelkova P; Martasek P; Raboch J
    Curr Alzheimer Res; 2018; 15(10):938-950. PubMed ID: 29852871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of neurovascular uncoupling: APOE status is a key driver of early metabolic and vascular dysfunction.
    Onos KD; Lin PB; Pandey RS; Persohn SA; Burton CP; Miner EW; Eldridge K; Kanyinda JN; Foley KE; Carter GW; Howell GR; Territo PR
    Alzheimers Dement; 2024 Jul; 20(7):4951-4969. PubMed ID: 38713704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
    Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
    Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells derived from one 70-years-old male donor with the APOE-ε4/ε4 alleles.
    Wang J; Liu X; Du X; Ma Z; Liu B; Guo R; Feng B; Ma J; Cui H
    Stem Cell Res; 2021 May; 53():102395. PubMed ID: 34088020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.
    Neu SC; Pa J; Kukull W; Beekly D; Kuzma A; Gangadharan P; Wang LS; Romero K; Arneric SP; Redolfi A; Orlandi D; Frisoni GB; Au R; Devine S; Auerbach S; Espinosa A; Boada M; Ruiz A; Johnson SC; Koscik R; Wang JJ; Hsu WC; Chen YL; Toga AW
    JAMA Neurol; 2017 Oct; 74(10):1178-1189. PubMed ID: 28846757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.
    Giannisis A; Al-Grety A; Carlsson H; Patra K; Twohig D; Sando SB; Lauridsen C; Berge G; Grøntvedt GR; Bråthen G; White LR; Kultima K; Nielsen HM
    Alzheimers Res Ther; 2022 Aug; 14(1):115. PubMed ID: 36002891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.